Evidence map›Paper›PMID 27148168›Full record

ArticleFrontiers in microbiology2016

Staphylococcal Enterotoxin O Exhibits Cell Cycle Modulating Activity.

Elisabeth Hodille, Ludmila Alekseeva, Nadia Berkova, Asma Serrier, Cedric Badiou, Benoit Gilquin, Virginie Brun, François Vandenesch, David S Terman, Gerard Lina

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Skin Cancer-AssociatedCancers · 2022
    Article
  5. Frontiers in cellular and infection microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Elisabeth HodilleInternational Center for Infectiology ResearchLyon, France; CNRS UMR5308, Inserm U1111, Ecole Normale Supérieure de Lyon - Université Lyon 1Lyon, France; Institut des Agents Infectieux, Hospices Civils de LyonLyon, France.
Ludmila AlekseevaUMR1253 STLO, Agrocampus Ouest, Institut National de la Recherche AgronomiqueRennes, France; Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryMoscow, Russia.
Nadia BerkovaUMR1253 STLO, Agrocampus Ouest, Institut National de la Recherche Agronomique Rennes, France.
Asma SerrierInternational Center for Infectiology ResearchLyon, France; CNRS UMR5308, Inserm U1111, Ecole Normale Supérieure de Lyon - Université Lyon 1Lyon, France.
Cedric BadiouInternational Center for Infectiology ResearchLyon, France; CNRS UMR5308, Inserm U1111, Ecole Normale Supérieure de Lyon - Université Lyon 1Lyon, France.
Benoit GilquiniRTSV-BGE, Université Grenoble AlpesGrenoble, France; CEA, iRTSV-BGEGrenoble, France; Biologie à Grande Echelle, Institut National de la Santé et de la Recherche MédicaleGrenoble, France.
Virginie BruniRTSV-BGE, Université Grenoble AlpesGrenoble, France; CEA, iRTSV-BGEGrenoble, France; Biologie à Grande Echelle, Institut National de la Santé et de la Recherche MédicaleGrenoble, France.
François VandeneschInternational Center for Infectiology ResearchLyon, France; CNRS UMR5308, Inserm U1111, Ecole Normale Supérieure de Lyon - Université Lyon 1Lyon, France; Institut des Agents Infectieux, Hospices Civils de LyonLyon, France.
David S TermanJenomic Research Institute, Carmel CA, USA.
Gerard LinaInternational Center for Infectiology ResearchLyon, France; CNRS UMR5308, Inserm U1111, Ecole Normale Supérieure de Lyon - Université Lyon 1Lyon, France; Institut des Agents Infectieux, Hospices Civils de LyonLyon, France.
Institut Agro Rennes-Angers · FRUniversité Claude Bernard Lyon 1 · FRCEA Grenoble · FRCentre International de Recherche en Infectiologie · FRCentre National de la Recherche Scientifique · FRÉcole Normale Supérieure de Lyon · FRLaboratoire Biologie à Grande Échelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintenance of an intact epithelial barrier constitutes a pivotal defense mechanism against infections. Staphylococcus aureus is a versatile pathogen that produces multiple factors including exotoxins that promote tissue alterations. The aim of the present study is to investigate the cytopathic effect of staphylococcal exotoxins SEA, SEG, SEI, SElM, SElN and SElO on the cell cycle of various human cell lines. Among all tested exotoxins only SEIO inhibited the proliferation of a broad panel of human tumor cell lines in vitro. Evaluation of a LDH release and a DNA fragmentation of host cells exposed to SEIO revealed that the toxin does not induce necrosis or apoptosis. Analysis of the DNA content of tumor cells synchronized by serum starvation after exposure to SEIO showed G0/G1 cell cycle delay. The cell cycle modulating feature of SEIO was confirmed by the flow cytometry analysis of synchronized cells exposed to supernatants of isogenic S. aureus strains wherein only supernatant of the SElO producing strain induced G0/G1 phase delay. The results of yeast-two-hybrid analysis indicated that SEIO's potential partner is cullin-3, involved in the transition from G1 to S phase. In conclusion, we provide evidence that SEIO inhibits cell proliferation without inducing cell death, by delaying host cell entry into the G0/G1 phase of the cell cycle. We speculate that this unique cell cycle modulating feature allows SEIO producing bacteria to gain advantage by arresting the cell cycle of target cells as part of a broader invasive strategy.

Indexed as

cell cycle alterationcullin-3cyclomodulinenterotoxin OG0/G1 phase delayStaphylococcus aureus

Identifiers

PMID27148168
PMCPMC4832122
OpenAlexW2339666532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.